Highstreet Asset Management Inc. reduced its stake in UnitedHealth Group Inc (NYSE:UNH) by 6.1% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 20,011 shares of the healthcare conglomerate’s stock after selling 1,297 shares during the period. Highstreet Asset Management Inc.’s holdings in UnitedHealth Group were worth $5,324,000 at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. Argent Trust Co boosted its holdings in shares of UnitedHealth Group by 8.3% in the 4th quarter. Argent Trust Co now owns 13,911 shares of the healthcare conglomerate’s stock valued at $3,066,000 after buying an additional 1,061 shares in the last quarter. Cornerstone Wealth Management LLC boosted its holdings in shares of UnitedHealth Group by 24,755.2% in the 2nd quarter. Cornerstone Wealth Management LLC now owns 245,569 shares of the healthcare conglomerate’s stock valued at $992,000 after buying an additional 244,581 shares in the last quarter. Greystone Managed Investments Inc. boosted its holdings in shares of UnitedHealth Group by 0.9% in the 2nd quarter. Greystone Managed Investments Inc. now owns 52,225 shares of the healthcare conglomerate’s stock valued at $12,813,000 after buying an additional 449 shares in the last quarter. Gilman Hill Asset Management LLC bought a new stake in shares of UnitedHealth Group in the 2nd quarter valued at about $207,000. Finally, Intl Fcstone Inc. boosted its holdings in shares of UnitedHealth Group by 22.1% in the 2nd quarter. Intl Fcstone Inc. now owns 1,842 shares of the healthcare conglomerate’s stock valued at $452,000 after buying an additional 333 shares in the last quarter. Institutional investors and hedge funds own 85.45% of the company’s stock.
In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 163 shares of the firm’s stock in a transaction that occurred on Friday, November 9th. The shares were sold at an average price of $274.83, for a total transaction of $44,797.29. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Steven H. Nelson sold 8,142 shares of the firm’s stock in a transaction that occurred on Thursday, September 13th. The stock was sold at an average price of $265.00, for a total transaction of $2,157,630.00. Following the transaction, the chief executive officer now directly owns 22,496 shares of the company’s stock, valued at $5,961,440. The disclosure for this sale can be found here. Insiders have sold a total of 54,338 shares of company stock valued at $14,516,459 over the last three months. 0.87% of the stock is currently owned by insiders.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.30 by $0.11. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.62%. The company had revenue of $56.56 billion during the quarter, compared to analyst estimates of $56.34 billion. During the same period last year, the firm posted $2.66 EPS. UnitedHealth Group’s revenue for the quarter was up 12.4% compared to the same quarter last year. As a group, equities research analysts forecast that UnitedHealth Group Inc will post 12.81 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 13th. Shareholders of record on Monday, December 3rd will be given a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a yield of 1.38%. The ex-dividend date is Friday, November 30th. UnitedHealth Group’s dividend payout ratio is presently 35.75%.
A number of analysts have recently weighed in on UNH shares. Bank of America raised their price target on shares of UnitedHealth Group from $315.00 to $320.00 and gave the company a “buy” rating in a report on Wednesday, October 17th. Cantor Fitzgerald reiterated a “buy” rating and issued a $300.00 target price on shares of UnitedHealth Group in a research note on Thursday, August 9th. Jefferies Financial Group lifted their target price on shares of UnitedHealth Group from $270.00 to $311.00 and gave the stock a “buy” rating in a research note on Wednesday, October 3rd. ValuEngine upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Tuesday, October 2nd. Finally, Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $299.00 target price for the company in a research note on Tuesday, September 25th. Two research analysts have rated the stock with a hold rating, twenty-one have assigned a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $289.86.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Read More: Moving Average (MA)
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.